lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis: Am J Cancer Res. 2023; 13(6): 2732-2750
American Journal of Cancer Research · 2026 · 16 (6) · 2677-2678
DOI: 10.62347/zzca7234 ↗Kurz gefasst
Korrektur in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Zong-Ying Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Affiliated Hospital of Chengde Medical University Chengde, Hebei, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Affiliated Hospital of Chengde Medical University Chengde, Hebei, China.
- Department of Education Division, The Affiliated Hospital of Chengde Medical University Chengde, Hebei, China.
Zitieren
APA
Liang, Z. Y., Zhang, Z. M., Sun, G. R., Zhao, B. S., Xin, G. H., & Zhang, L. (2026). lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis: Am J Cancer Res. 2023; 13(6): 2732-2750. American Journal of Cancer Research, 16(6), 2677-2678. https://doi.org/10.62347/zzca7234
Vancouver
Liang ZY, Zhang ZM, Sun GR, Zhao BS, Xin GH, Zhang L. lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis: Am J Cancer Res. 2023; 13(6): 2732-2750. American Journal of Cancer Research. 2026;16(6):2677-2678. doi:10.62347/zzca7234
BibTeX
@article{Liang2026,
author = {Liang, Zong-Ying and Zhang, Zhi-Min and Sun, Guang-Rui and Zhao, Bao-Shan and Xin, Guo-Hua and Zhang, Le},
title = {lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis: Am J Cancer Res. 2023; 13(6): 2732-2750},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {6},
pages = {2677--2678},
doi = {10.62347/zzca7234}
}
EUVIMED